Focused Wealth Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,800
Closed -$41.5K 761
2023
Q4
$41.5K Hold
1,800
0.01% 331
2023
Q3
$41.4K Hold
1,800
0.01% 314
2023
Q2
$47K Hold
1,800
0.01% 314
2023
Q1
$49.7K Hold
1,800
0.01% 309
2022
Q4
$40.9K Buy
+1,800
New +$50.1K 0.01% 332

Other funds holding PRVA

Focused Wealth Management's PRVA Position: Q1 2024 in Review

Focused Wealth Management sold out of Privia Health (PRVA) in Q1 2024, closing a stake of 1,800 shares — an estimated $41.5K sold.

Focused Wealth Management first reported a position in PRVA in Q4 2022 and held it in 5 quarters. The position peaked at $49.7K in Q1 2023. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Focused Wealth Management reported no remaining Privia Health position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 1,800 Privia Health shares in Q1 2024, an estimated $41.5K.
  • Focused Wealth Management first reported a position in Privia Health in Q4 2022 and held it in 5 quarters.
  • Focused Wealth Management's Privia Health position peaked at $49.7K in Q1 2023.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.